Reduced graft function (with or without dialysis) vs immediate graft function—a comparison of long-term renal allograft survival

Background. Delayed graft function (DGF) is a common complication in cadaveric kidney transplants affecting graft outcome. However, the incidence of DGF differs widely between centres as its definition is very variable. The purpose of this study was to define a parameter for DGF and immediate graft...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrology, dialysis, transplantation dialysis, transplantation, 2006-08, Vol.21 (8), p.2270-2274
Hauptverfasser: Johnston, Olwyn, O'Kelly, Patrick, Spencer, Susan, Donohoe, John, Walshe, J. Joseph, Little, Dilly M., Hickey, David, Conlon, Peter J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2274
container_issue 8
container_start_page 2270
container_title Nephrology, dialysis, transplantation
container_volume 21
creator Johnston, Olwyn
O'Kelly, Patrick
Spencer, Susan
Donohoe, John
Walshe, J. Joseph
Little, Dilly M.
Hickey, David
Conlon, Peter J.
description Background. Delayed graft function (DGF) is a common complication in cadaveric kidney transplants affecting graft outcome. However, the incidence of DGF differs widely between centres as its definition is very variable. The purpose of this study was to define a parameter for DGF and immediate graft function (IGF) and to compare the graft outcome between these groups at our centre. Methods. The renal allograft function of 972 first cadaveric transplants performed between 1990 and 2001 in the Republic of Ireland was examined. The DGF and IGF were defined by a creatinine reduction ratio (CRR) between time 0 of transplantation and day 7 post-transplantation of 70%, respectively. Recipients with reduced graft function (DGF) not requiring dialysis were defined as slow graft function (SGF) patients. The serum creatinine at 3 months, 6 months, 1, 2 and 5 years after transplantation was compared between these groups of recipients. The graft survival rates at 1, 3 and 5 years and the graft half-life for DGF, SGF and IGF recipients were also assessed. Results. Of the 972 renal transplant recipients, DGF was seen in 102 (10.5%) patients, SGF in 202 (20.8%) recipients and IGF in 668 (68.7%) patients. Serum creatinine levels were significantly different between the three groups at 3 and 6 months, 1, 2 and 5 years. Graft survival at 5 years for the DGF patients was 48.5%, 60.5% for SGF recipients and 75% for IGF patients with graft half-life of 4.9, 8.7 and 10.5 years, respectively. Conclusion. This study has shown that the CRR at day 7 correlates with renal function up to 5 years post-transplantation and with long-term graft survival. We have also demonstrated that amongst patients with reduced graft function after transplantation, two groups with significantly different outcomes exist.
doi_str_mv 10.1093/ndt/gfl103
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68676755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19366718</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-8620ba61bba997b7be19f7e23ccada48ea624790d53c4333b7844d43019da14b3</originalsourceid><addsrcrecordid>eNqF0d1qFTEQB_BFFHus3vgAEgRFhbXJJpuPS60fVQqKqBRvwmw2e0yb3RyT7NHeic_gE_okpuzBQm-8Gsj8ZiDzr6q7BD8lWNGDqc8H68ETTK9VK8I4rhsq2-vVqjRJjVus9qpbKZ1ijFUjxM1qj3DR4FbJVfXrg-1nY3u0jjBkNMyTyS5M6NF3l7-iENFFDXNGvQN_nlx6jLYJuXG05SHbK2N_fv4GZMK4gehS2RIG5MO0rrONI4p2Ao_A-7AMpTlu3Rb87erGAD7ZO7u6X3169fLj4VF9_O71m8Nnx7VhTORa8gZ3wEnXgVKiE50lahC2ocZAD0xa4A0TCvctNYxS2gnJWM8oJqoHwjq6Xz1c9m5i-DbblPXokrHew2TDnDSXXHDRtv-FRFHOBZEF3r8CT8Mcyy-TbogkHMu2KejJgkwMKUU76E10I8RzTbC-yE-X_PSSX8H3dhvnrpz4ku4CK-DBDkAy4IcIk3Hp0klMOeaiuHpxLmX7418f4pkuXdHqo5MvWp58fv-cvxD6Lf0LRhG1lw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218160852</pqid></control><display><type>article</type><title>Reduced graft function (with or without dialysis) vs immediate graft function—a comparison of long-term renal allograft survival</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Johnston, Olwyn ; O'Kelly, Patrick ; Spencer, Susan ; Donohoe, John ; Walshe, J. Joseph ; Little, Dilly M. ; Hickey, David ; Conlon, Peter J.</creator><creatorcontrib>Johnston, Olwyn ; O'Kelly, Patrick ; Spencer, Susan ; Donohoe, John ; Walshe, J. Joseph ; Little, Dilly M. ; Hickey, David ; Conlon, Peter J.</creatorcontrib><description>Background. Delayed graft function (DGF) is a common complication in cadaveric kidney transplants affecting graft outcome. However, the incidence of DGF differs widely between centres as its definition is very variable. The purpose of this study was to define a parameter for DGF and immediate graft function (IGF) and to compare the graft outcome between these groups at our centre. Methods. The renal allograft function of 972 first cadaveric transplants performed between 1990 and 2001 in the Republic of Ireland was examined. The DGF and IGF were defined by a creatinine reduction ratio (CRR) between time 0 of transplantation and day 7 post-transplantation of &lt;70 and &gt;70%, respectively. Recipients with reduced graft function (DGF) not requiring dialysis were defined as slow graft function (SGF) patients. The serum creatinine at 3 months, 6 months, 1, 2 and 5 years after transplantation was compared between these groups of recipients. The graft survival rates at 1, 3 and 5 years and the graft half-life for DGF, SGF and IGF recipients were also assessed. Results. Of the 972 renal transplant recipients, DGF was seen in 102 (10.5%) patients, SGF in 202 (20.8%) recipients and IGF in 668 (68.7%) patients. Serum creatinine levels were significantly different between the three groups at 3 and 6 months, 1, 2 and 5 years. Graft survival at 5 years for the DGF patients was 48.5%, 60.5% for SGF recipients and 75% for IGF patients with graft half-life of 4.9, 8.7 and 10.5 years, respectively. Conclusion. This study has shown that the CRR at day 7 correlates with renal function up to 5 years post-transplantation and with long-term graft survival. We have also demonstrated that amongst patients with reduced graft function after transplantation, two groups with significantly different outcomes exist.</description><identifier>ISSN: 0931-0509</identifier><identifier>EISSN: 1460-2385</identifier><identifier>DOI: 10.1093/ndt/gfl103</identifier><identifier>PMID: 16720598</identifier><identifier>CODEN: NDTREA</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Cadaver ; Creatinine - blood ; delayed graft function ; Delayed Graft Function - epidemiology ; Emergency and intensive care: renal failure. Dialysis management ; Female ; Follow-Up Studies ; graft outcome ; Graft Survival ; Humans ; Intensive care medicine ; Ireland - epidemiology ; Kidney - physiopathology ; kidney transplantation ; Kidney Transplantation - statistics &amp; numerical data ; Male ; Medical sciences ; Middle Aged ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Postoperative Period ; Prognosis ; Registries ; Renal failure ; Retrospective Studies ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; Transplantation, Homologous ; Treatment Outcome</subject><ispartof>Nephrology, dialysis, transplantation, 2006-08, Vol.21 (8), p.2270-2274</ispartof><rights>2006 INIST-CNRS</rights><rights>Copyright Oxford Publishing Limited(England) Aug 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-8620ba61bba997b7be19f7e23ccada48ea624790d53c4333b7844d43019da14b3</citedby><cites>FETCH-LOGICAL-c447t-8620ba61bba997b7be19f7e23ccada48ea624790d53c4333b7844d43019da14b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18036067$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16720598$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Johnston, Olwyn</creatorcontrib><creatorcontrib>O'Kelly, Patrick</creatorcontrib><creatorcontrib>Spencer, Susan</creatorcontrib><creatorcontrib>Donohoe, John</creatorcontrib><creatorcontrib>Walshe, J. Joseph</creatorcontrib><creatorcontrib>Little, Dilly M.</creatorcontrib><creatorcontrib>Hickey, David</creatorcontrib><creatorcontrib>Conlon, Peter J.</creatorcontrib><title>Reduced graft function (with or without dialysis) vs immediate graft function—a comparison of long-term renal allograft survival</title><title>Nephrology, dialysis, transplantation</title><addtitle>Nephrol. Dial. Transplant</addtitle><description>Background. Delayed graft function (DGF) is a common complication in cadaveric kidney transplants affecting graft outcome. However, the incidence of DGF differs widely between centres as its definition is very variable. The purpose of this study was to define a parameter for DGF and immediate graft function (IGF) and to compare the graft outcome between these groups at our centre. Methods. The renal allograft function of 972 first cadaveric transplants performed between 1990 and 2001 in the Republic of Ireland was examined. The DGF and IGF were defined by a creatinine reduction ratio (CRR) between time 0 of transplantation and day 7 post-transplantation of &lt;70 and &gt;70%, respectively. Recipients with reduced graft function (DGF) not requiring dialysis were defined as slow graft function (SGF) patients. The serum creatinine at 3 months, 6 months, 1, 2 and 5 years after transplantation was compared between these groups of recipients. The graft survival rates at 1, 3 and 5 years and the graft half-life for DGF, SGF and IGF recipients were also assessed. Results. Of the 972 renal transplant recipients, DGF was seen in 102 (10.5%) patients, SGF in 202 (20.8%) recipients and IGF in 668 (68.7%) patients. Serum creatinine levels were significantly different between the three groups at 3 and 6 months, 1, 2 and 5 years. Graft survival at 5 years for the DGF patients was 48.5%, 60.5% for SGF recipients and 75% for IGF patients with graft half-life of 4.9, 8.7 and 10.5 years, respectively. Conclusion. This study has shown that the CRR at day 7 correlates with renal function up to 5 years post-transplantation and with long-term graft survival. We have also demonstrated that amongst patients with reduced graft function after transplantation, two groups with significantly different outcomes exist.</description><subject>Adult</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Cadaver</subject><subject>Creatinine - blood</subject><subject>delayed graft function</subject><subject>Delayed Graft Function - epidemiology</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>graft outcome</subject><subject>Graft Survival</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Ireland - epidemiology</subject><subject>Kidney - physiopathology</subject><subject>kidney transplantation</subject><subject>Kidney Transplantation - statistics &amp; numerical data</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Postoperative Period</subject><subject>Prognosis</subject><subject>Registries</subject><subject>Renal failure</subject><subject>Retrospective Studies</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>Transplantation, Homologous</subject><subject>Treatment Outcome</subject><issn>0931-0509</issn><issn>1460-2385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0d1qFTEQB_BFFHus3vgAEgRFhbXJJpuPS60fVQqKqBRvwmw2e0yb3RyT7NHeic_gE_okpuzBQm-8Gsj8ZiDzr6q7BD8lWNGDqc8H68ETTK9VK8I4rhsq2-vVqjRJjVus9qpbKZ1ijFUjxM1qj3DR4FbJVfXrg-1nY3u0jjBkNMyTyS5M6NF3l7-iENFFDXNGvQN_nlx6jLYJuXG05SHbK2N_fv4GZMK4gehS2RIG5MO0rrONI4p2Ao_A-7AMpTlu3Rb87erGAD7ZO7u6X3169fLj4VF9_O71m8Nnx7VhTORa8gZ3wEnXgVKiE50lahC2ocZAD0xa4A0TCvctNYxS2gnJWM8oJqoHwjq6Xz1c9m5i-DbblPXokrHew2TDnDSXXHDRtv-FRFHOBZEF3r8CT8Mcyy-TbogkHMu2KejJgkwMKUU76E10I8RzTbC-yE-X_PSSX8H3dhvnrpz4ku4CK-DBDkAy4IcIk3Hp0klMOeaiuHpxLmX7418f4pkuXdHqo5MvWp58fv-cvxD6Lf0LRhG1lw</recordid><startdate>20060801</startdate><enddate>20060801</enddate><creator>Johnston, Olwyn</creator><creator>O'Kelly, Patrick</creator><creator>Spencer, Susan</creator><creator>Donohoe, John</creator><creator>Walshe, J. Joseph</creator><creator>Little, Dilly M.</creator><creator>Hickey, David</creator><creator>Conlon, Peter J.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20060801</creationdate><title>Reduced graft function (with or without dialysis) vs immediate graft function—a comparison of long-term renal allograft survival</title><author>Johnston, Olwyn ; O'Kelly, Patrick ; Spencer, Susan ; Donohoe, John ; Walshe, J. Joseph ; Little, Dilly M. ; Hickey, David ; Conlon, Peter J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-8620ba61bba997b7be19f7e23ccada48ea624790d53c4333b7844d43019da14b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Cadaver</topic><topic>Creatinine - blood</topic><topic>delayed graft function</topic><topic>Delayed Graft Function - epidemiology</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>graft outcome</topic><topic>Graft Survival</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Ireland - epidemiology</topic><topic>Kidney - physiopathology</topic><topic>kidney transplantation</topic><topic>Kidney Transplantation - statistics &amp; numerical data</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Postoperative Period</topic><topic>Prognosis</topic><topic>Registries</topic><topic>Renal failure</topic><topic>Retrospective Studies</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>Transplantation, Homologous</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Johnston, Olwyn</creatorcontrib><creatorcontrib>O'Kelly, Patrick</creatorcontrib><creatorcontrib>Spencer, Susan</creatorcontrib><creatorcontrib>Donohoe, John</creatorcontrib><creatorcontrib>Walshe, J. Joseph</creatorcontrib><creatorcontrib>Little, Dilly M.</creatorcontrib><creatorcontrib>Hickey, David</creatorcontrib><creatorcontrib>Conlon, Peter J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Nephrology, dialysis, transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Johnston, Olwyn</au><au>O'Kelly, Patrick</au><au>Spencer, Susan</au><au>Donohoe, John</au><au>Walshe, J. Joseph</au><au>Little, Dilly M.</au><au>Hickey, David</au><au>Conlon, Peter J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced graft function (with or without dialysis) vs immediate graft function—a comparison of long-term renal allograft survival</atitle><jtitle>Nephrology, dialysis, transplantation</jtitle><addtitle>Nephrol. Dial. Transplant</addtitle><date>2006-08-01</date><risdate>2006</risdate><volume>21</volume><issue>8</issue><spage>2270</spage><epage>2274</epage><pages>2270-2274</pages><issn>0931-0509</issn><eissn>1460-2385</eissn><coden>NDTREA</coden><abstract>Background. Delayed graft function (DGF) is a common complication in cadaveric kidney transplants affecting graft outcome. However, the incidence of DGF differs widely between centres as its definition is very variable. The purpose of this study was to define a parameter for DGF and immediate graft function (IGF) and to compare the graft outcome between these groups at our centre. Methods. The renal allograft function of 972 first cadaveric transplants performed between 1990 and 2001 in the Republic of Ireland was examined. The DGF and IGF were defined by a creatinine reduction ratio (CRR) between time 0 of transplantation and day 7 post-transplantation of &lt;70 and &gt;70%, respectively. Recipients with reduced graft function (DGF) not requiring dialysis were defined as slow graft function (SGF) patients. The serum creatinine at 3 months, 6 months, 1, 2 and 5 years after transplantation was compared between these groups of recipients. The graft survival rates at 1, 3 and 5 years and the graft half-life for DGF, SGF and IGF recipients were also assessed. Results. Of the 972 renal transplant recipients, DGF was seen in 102 (10.5%) patients, SGF in 202 (20.8%) recipients and IGF in 668 (68.7%) patients. Serum creatinine levels were significantly different between the three groups at 3 and 6 months, 1, 2 and 5 years. Graft survival at 5 years for the DGF patients was 48.5%, 60.5% for SGF recipients and 75% for IGF patients with graft half-life of 4.9, 8.7 and 10.5 years, respectively. Conclusion. This study has shown that the CRR at day 7 correlates with renal function up to 5 years post-transplantation and with long-term graft survival. We have also demonstrated that amongst patients with reduced graft function after transplantation, two groups with significantly different outcomes exist.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>16720598</pmid><doi>10.1093/ndt/gfl103</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0931-0509
ispartof Nephrology, dialysis, transplantation, 2006-08, Vol.21 (8), p.2270-2274
issn 0931-0509
1460-2385
language eng
recordid cdi_proquest_miscellaneous_68676755
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adult
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Cadaver
Creatinine - blood
delayed graft function
Delayed Graft Function - epidemiology
Emergency and intensive care: renal failure. Dialysis management
Female
Follow-Up Studies
graft outcome
Graft Survival
Humans
Intensive care medicine
Ireland - epidemiology
Kidney - physiopathology
kidney transplantation
Kidney Transplantation - statistics & numerical data
Male
Medical sciences
Middle Aged
Nephrology. Urinary tract diseases
Nephropathies. Renovascular diseases. Renal failure
Postoperative Period
Prognosis
Registries
Renal failure
Retrospective Studies
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
Transplantation, Homologous
Treatment Outcome
title Reduced graft function (with or without dialysis) vs immediate graft function—a comparison of long-term renal allograft survival
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T10%3A50%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20graft%20function%20(with%20or%20without%20dialysis)%20vs%20immediate%20graft%20function%E2%80%94a%20comparison%20of%20long-term%20renal%20allograft%20survival&rft.jtitle=Nephrology,%20dialysis,%20transplantation&rft.au=Johnston,%20Olwyn&rft.date=2006-08-01&rft.volume=21&rft.issue=8&rft.spage=2270&rft.epage=2274&rft.pages=2270-2274&rft.issn=0931-0509&rft.eissn=1460-2385&rft.coden=NDTREA&rft_id=info:doi/10.1093/ndt/gfl103&rft_dat=%3Cproquest_cross%3E19366718%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218160852&rft_id=info:pmid/16720598&rfr_iscdi=true